News Search

Dr. Eldad Hod talks on his efforts to implement serological testing to identify patients who have recovered from COVID-19 and who may qualify as convalescent plasma donors.

Pathology laboratory screened New York state’s first potential donor—a COVID-19 survivor for antibodies that can be used to treat or vaccine against COVID-19.

He was appointed to a three year term as a Louis V. Gerstner Jr. Scholar effective July 1, 2020 through June 30, 2023.

A team led by Pathology researcher, Alex Chavez, MD, PhD, will use a new drug screening approach to rapidly screen a large number of compounds that block the protease of 2019-nCoV.